Related Experiment Video
Updated: Jul 10, 2026

05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Prioritized subset analysis: improving power in genome-wide association studies
Chun Li1, Mingyao Li, Ethan M Lange
1Department of Biostatistics, Center for Human Genetics Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. chun.li@vanderbilt.edu
Human Heredity
|October 16, 2007
Summary
Prioritized Subset Analysis (PSA) enhances genome-wide association studies (GWAS) by focusing on candidate regions. This method improves the power to detect disease variants compared to traditional approaches.
Area of Science:
- Genetics
- Statistical genomics
- Bioinformatics
Background:
- Genome-wide association studies (GWAS) are crucial for understanding complex disease genetics.
- Existing candidate gene information can enhance GWAS power but is often underutilized.
- Traditional GWAS methods treat all genetic markers equally, potentially reducing power to detect variants.
Purpose of the Study:
- To introduce a novel analytical approach, Prioritized Subset Analysis (PSA), for GWAS.
- To leverage prior biological information to improve the detection of disease-associated variants.
- To compare the statistical power of PSA against standard whole-genome analysis.
Main Methods:
- PSA involves pre-selecting a subset of genetic markers from known candidate regions.
- The false discovery rate (FDR) procedure is applied separately to the prioritized subset and the remaining markers.
- This approach allows for differential analysis based on prior biological knowledge.
Main Results:
- PSA demonstrates superior statistical power compared to whole-genome single-step FDR adjustment.
- The extent of power improvement is contingent on the proportion and significance of associated single nucleotide polymorphisms (SNPs) within the prioritized subset.
- Negligible power loss is observed for disease loci outside the prioritized subset.
Conclusions:
- PSA offers a flexible framework for integrating diverse sources of prior biological information into GWAS.
- This method represents a valuable advancement for genetic analysis in complex diseases.
- PSA can enhance the efficiency and effectiveness of variant detection in genetic association studies.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
